On Monday, Outlook Therapeutics Inc (NASDAQ: OTLK) opened lower -8.46% from the last session, before settling in for the closing price of $2.01. Price fluctuations for OTLK have ranged from $0.79 to $3.39 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 33.18% over the past five years. Company’s average yearly earnings per share was noted 60.34% at the time writing. With a float of $29.09 million, this company’s outstanding shares have now reached $43.48 million.
Outlook Therapeutics Inc (OTLK) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Outlook Therapeutics Inc is 34.52%, while institutional ownership is 9.11%.
Outlook Therapeutics Inc (OTLK) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.89 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.75) by -0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 60.34% per share during the next fiscal year.
Outlook Therapeutics Inc (NASDAQ: OTLK) Trading Performance Indicators
Check out the current performance indicators for Outlook Therapeutics Inc (OTLK). In the past quarter, the stock posted a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 54.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.09, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Outlook Therapeutics Inc (OTLK)
Outlook Therapeutics Inc (NASDAQ: OTLK) saw its 5-day average volume 5.22 million, a positive change from its year-to-date volume of 2.03 million. As of the previous 9 days, the stock’s Stochastic %D was 27.02%.
During the past 100 days, Outlook Therapeutics Inc’s (OTLK) raw stochastic average was set at 40.38%, which indicates a significant increase from 18.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.64, while its 200-day Moving Average is $1.62. Nevertheless, the first resistance level for the watch stands at $2.03 in the near term. At $2.23, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.40. If the price goes on to break the first support level at $1.66, it is likely to go to the next support level at $1.49. Assuming the price breaks the second support level, the third support level stands at $1.29.
Outlook Therapeutics Inc (NASDAQ: OTLK) Key Stats
There are currently 44,420K shares outstanding in the company with a market cap of 81.73 million. Presently, the company’s annual sales total 1,410 K according to its annual income of -62,430 K. Last quarter, the company’s sales amounted to 1,510 K and its income totaled -20,150 K.
